- Report
- May 2025
- 628 Pages
Global
From €6351EUR$7,150USD£5,533GBP
- Report
- February 2026
- 184 Pages
Global
From €4263EUR$4,799USD£3,714GBP
- Report
- February 2026
- 189 Pages
Global
From €4263EUR$4,799USD£3,714GBP
- Report
- October 2025
- 164 Pages
Global
From €4130EUR$4,650USD£3,599GBP
- Report
- February 2026
- 255 Pages
Global
From €3686EUR$4,150USD£3,212GBP
- Report
- June 2025
- 140 Pages
Global
From €3552EUR$3,999USD£3,095GBP
- Report
- April 2026
- 93 Pages
Global
From €2620EUR$2,950USD£2,283GBP
- Report
- January 2026
- 120 Pages
Global
From €5285EUR$5,950USD£4,605GBP
- Report
- August 2025
- 250 Pages
Global
From €2221EUR$2,500USD£1,935GBP
- Report
- August 2025
- 234 Pages
Global
From €2221EUR$2,500USD£1,935GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- November 2025
- 150 Pages
Global
From €4397EUR$4,950USD£3,831GBP
- Report
- May 2026
- 142 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 140 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 212 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 245 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more